Telerehabilitation in Multiple Sclerosis
Sponsor
Marmara University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04979845
Collaborator
(none)
30
1
2
6
5
Study Details
Study Description
Brief Summary
Patients with multiple sclerosis will be randomized into two groups. One group will receive live telerehabilitation sessions 3 times a week over a course of three months. The other group will receive video instructions for aerobic and strengthening exercises. Patients fatigue, sleep quality and quality of life will be measured.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect on Telerehabilitation on Fatigue and Sleep Quality in Patients With Multiple Sclerosis
Actual Study Start Date
:
Jul 1, 2021
Anticipated Primary Completion Date
:
Dec 31, 2021
Anticipated Study Completion Date
:
Dec 31, 2021
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Telerehabilitation
|
Other: Telerehabilitation
Patients will receive telerehabilitation sessions for 12 weeks including aerobic and strengthening exercises
|
| Active Comparator: Video exercise
|
Other: Video exercise
Patients will receive video instructions for home based exercises
|
Outcome Measures
Primary Outcome Measures
- Pittsburgh Sleep Quality Scale [3 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Diagnosis of multiple scleroisis
Exclusion Criteria:
- Any musculoskeletal condition preventing patients to actively participate in exercise sessions
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Marmara University School of Medicine Department of Physical Medicine and Rehabilitation | Istanbul | Turkey | 34899 |
Sponsors and Collaborators
- Marmara University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Marmara University
ClinicalTrials.gov Identifier:
NCT04979845
Other Study ID Numbers:
- 2021.808
First Posted:
Jul 28, 2021
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: